About: Adam Bucki

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Adam Bucki Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Polish pharmaceutical chemist and researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 연구원 (ko) investigador (es) araştırmacı (tr) wetenschapper (nl) 研究者 (zh) польський дослідник (uk) Polish pharmaceutical chemist and researcher (en) polski naukowiec, zajmujący się chemią leków (pl)
rdfs:label	Adam Bucki (ca) Adam Bucki (cs) Adam Bucki (en) Adam Bucki (es) Adam Bucki (gl) Adam Bucki (hr) Adam Bucki (it) Adam Bucki (nl) Adam Bucki (pl) Adam Bucki (ro) Adam Bucki (sk) Adam Bucki (sl) Adam Bucki (hsb) Adam Bucki (ast)
skos:prefLabel	Adam Bucki (ca) Adam Bucki (cs) Adam Bucki (en) Adam Bucki (es) Adam Bucki (gl) Adam Bucki (hr) Adam Bucki (it) Adam Bucki (nl) Adam Bucki (pl) Adam Bucki (ro) Adam Bucki (sk) Adam Bucki (sl) Adam Bucki (hsb) Adam Bucki (ast)
name	Adam Bucki (ca) Adam Bucki (cs) Adam Bucki (en) Adam Bucki (es) Adam Bucki (gl) Adam Bucki (hr) Adam Bucki (it) Adam Bucki (nl) Adam Bucki (pl) Adam Bucki (ro) Adam Bucki (sk) Adam Bucki (sl) Adam Bucki (hsb) Adam Bucki (ast)
Polish scientist ID (deprecated)	wds:Q87651683-32468358-0532-478C-AF6A-AE384FC3007B
Polish scientist ID (deprecated)	255873
affiliation	wds:Q87651683-29835185-3FB9-4020-A192-2DF09BDA036B
affiliation	Chair of Pharmaceutical Chemistry, Jagiellonian University
Scopus author ID	wds:Q87651683-3BD78434-882E-4F94-AD10-F27A92D31D72
Scopus author ID	6506862487
given name	wds:Q87651683-7784976F-C1D0-4283-B23C-01627F943AC6
given name	Adam
instance of	wds:Q87651683-660CB708-3302-4C3B-8911-C67AC7E77336
instance of	Homo sapiens
doctoral advisor	wds:Q87651683-E6BE31EE-8FFD-4F98-B5E6-AE0405063C56
doctoral advisor	Maciej Pawłowski
native language	wds:Q87651683-AFF07D9C-0D0E-4F90-90B2-B9FA40BE97DC
occupation	wds:Q87651683-60ADE4D1-B673-473E-9B98-019D9FBED85D wds:Q87651683-DF9E5DE7-B528-4375-B0D1-F8CB9BD2AB3F
employer	wds:Q87651683-53F50CF6-3674-4F11-850E-E6C04CD22FB9
languages spoken, written or signed	wds:Q87651683-5C630A67-D5D3-4844-9837-651E7F9B7C07
name in native language	wds:Q87651683-C7D4DCB3-1A7B-48A2-A33F-277FD54F1F78
sex or gender	wds:Q87651683-0F722D7F-162F-4251-B3CC-BC4F9C65549E
country of citizenship	wds:Q87651683-A527AECB-B44D-45ED-A498-5328938B9ADE
family name	wds:Q87651683-496127F9-9B1C-44CF-803A-D3F6B3EA0EF7
native language	Polish
occupation	researcher pharmaceutical chemist
employer	Medical College of Jagiellonian University
languages spoken, written or signed	Polish
name in native language	Adam Bucki (pl)
sex or gender	male
country of citizenship	Poland
family name	Bucki
ORCID iD	wds:Q87651683-83FF728B-4BA1-4648-A62E-28533CE835AB
ORCID iD	https://orcid.org/0000-0003-0451-9814
ORCID iD	0000-0003-0451-9814
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87651683
is author of	Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation. Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity. Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition Functional selectivity – chance for better and safer drugs? Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Novel multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software